




Searching News Database: Salix Pharmaceuticals
HSMN NewsFeed - 6 May 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN(R) Intellectual Property Litigation
HSMN NewsFeed - 6 Aug 2018
US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA(TM) (lofexidine) 0.18 Mg Tablets
US WorldMeds and Salix Announce U.S. Launch of LUCEMYRA(TM) (lofexidine) 0.18 Mg Tablets
HSMN NewsFeed - 26 Dec 2017
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
Mallinckrodt To Acquire Sucampo Pharmaceuticals For Approximately $1.2 Billion
HSMN NewsFeed - 13 Apr 2017
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg
RedHill Biopharma and IntelGenx Announce Marketing Approval of RIZAPORT(R) for Migraines in Luxembourg
HSMN NewsFeed - 11 Nov 2016
CHMP Adopts Positive Opinion to Include Self-administration for RUCONEST(R)
CHMP Adopts Positive Opinion to Include Self-administration for RUCONEST(R)
HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
HSMN NewsFeed - 3 Oct 2014
Salix Pharmaceuticals and Cosmo Technologies Announce Termination of Merger Agreement
Salix Pharmaceuticals and Cosmo Technologies Announce Termination of Merger Agreement
HSMN NewsFeed - 15 Sep 2014
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
Antares Pharma Announces Promotion of Robert F. Apple to Chief Operating Officer
HSMN NewsFeed - 29 Jan 2014
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
Progenics Pharmaceuticals Announces the Appointment of Karen Ferrante, M.D. to Its Board of Directors
HSMN NewsFeed - 24 May 2013
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
HSMN NewsFeed - 30 Aug 2011
Progenics and Salix Announce FDA Acceptance of sNDA Filing for RELISTOR(R) in Patients with Non-Cancer Pain
Progenics and Salix Announce FDA Acceptance of sNDA Filing for RELISTOR(R) in Patients with Non-Cancer Pain
HSMN NewsFeed - 15 Mar 2011
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
HSMN NewsFeed - 24 Mar 2010
FDA Approves XIFAXAN(R) 550 MG Tablets for Reduction in Risk of Overt Hepatic Encephalopathy (HE) Recurrence
FDA Approves XIFAXAN(R) 550 MG Tablets for Reduction in Risk of Overt Hepatic Encephalopathy (HE) Recurrence
HSMN NewsFeed - 3 Nov 2009
FDA Approves New Salix Product Exclusively in Catalent's Zydis(R) Fast Dissolve Technology
FDA Approves New Salix Product Exclusively in Catalent's Zydis(R) Fast Dissolve Technology
HSMN NewsFeed - 4 Nov 2008
Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding - Debiopharm Submits Response to the FDA
Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding - Debiopharm Submits Response to the FDA
HSMN NewsFeed - 3 Nov 2008
APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
HSMN NewsFeed - 28 Jul 2008
AVI BioPharma Appoints New Senior Vice President and Chief Financial Officer
AVI BioPharma Appoints New Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 31 Dec 2007
Salix Pharmaceuticals Announces Submission of Granulated Mesalamine New Drug Application
Salix Pharmaceuticals Announces Submission of Granulated Mesalamine New Drug Application
HSMN NewsFeed - 5 Sep 2007
NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
NeoMatrix Announces Additional Funding for Breakthrough Breast Cancer Screening Test
HSMN NewsFeed - 5 Sep 2007
Eisai Inc. Enters Copromotion Agreement with Salix Pharmaceuticals, Ltd. for Balsalazide Products
Eisai Inc. Enters Copromotion Agreement with Salix Pharmaceuticals, Ltd. for Balsalazide Products
HSMN NewsFeed - 18 Jun 2007
Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
Salix Pharmaceuticals Announces Positive Top Line Results of Balsalazide Tablets Registration Study
HSMN NewsFeed - 7 Jun 2007
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
HSMN NewsFeed - 10 Jan 2007
Bradley Pharmaceuticals Announces Appointment of Dr. Leonard S. Jacob As Non-Executive Chair
Bradley Pharmaceuticals Announces Appointment of Dr. Leonard S. Jacob As Non-Executive Chair
HSMN NewsFeed - 23 Oct 2006
Salix Pharmaceuticals Reports American College of Gastroenterology Update
Salix Pharmaceuticals Reports American College of Gastroenterology Update
HSMN NewsFeed - 19 Apr 2006
Salix Announces Completion of OsmoPrep(TM) versus Liquid Bowel Cleanser Comparison Study
Salix Announces Completion of OsmoPrep(TM) versus Liquid Bowel Cleanser Comparison Study
Additional items found! 29

Members Archive contains
29 additional stories matching:
Salix Pharmaceuticals
(Password required)
Salix Pharmaceuticals
(Password required)